bucladesine and Parotid Neoplasms

bucladesine has been researched along with Parotid Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Krause, G; Kumar, R; Meyers, A; Prasad, KN1
Bando, T; Nagamine, S; Sato, M; Yanagawa, T; Yoshida, H; Yura, Y1

Other Studies

2 other study(ies) available for bucladesine and Parotid Neoplasms

ArticleYear
Effect of adenosine 3',5'-cyclic monophosphate (cAMP) on human non-tumorigenic and tumorigenic parotid acinar cells in culture.
    Cancer letters, 1996, Nov-12, Volume: 108, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Adenoma, Pleomorphic; Alprostadil; Bucladesine; Cell Differentiation; Cell Division; Cell Size; Cell Transformation, Neoplastic; Cells, Cultured; Colforsin; Cyclic AMP; Humans; Parotid Gland; Parotid Neoplasms; Phosphodiesterase Inhibitors; Receptors, Prostaglandin E; Tumor Cells, Cultured

1996
Induction of cells with phenotypic features of neuronal cells by treatment with dibutyryl cyclic adenosine 3',5'-monophosphate in a human parotid gland adenocarcinoma cell line in culture.
    Cancer research, 1990, Oct-01, Volume: 50, Issue:19

    Topics: Adenocarcinoma; Amylases; Bucladesine; Cytoskeleton; Fluorescent Antibody Technique; Humans; Intermediate Filaments; Parotid Neoplasms; Phenotype; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vasoactive Intestinal Peptide

1990